跳到主要內容

簡易檢索 / 詳目顯示

研究生: 施乃維
Shih,Nai-Wei
論文名稱: 外商與中國製藥產業:市場進入策略與永續培訓
Entering the Pharmaceutical Industry in China:Market Entry Strategies and Sustainable Training for Foreign Firms
指導教授: 冷則剛
學位類別: 碩士
Master
系所名稱: 商學院 - 國際經營管理英語碩士學位學程(IMBA)
International MBA Program College of Commerce(IMBA)
論文出版年: 2007
畢業學年度: 95
語文別: 英文
論文頁數: 66
中文關鍵詞: 永續培訓策略外商
相關次數: 點閱:165下載:0
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  • 外商與中國製藥產業:市場進入策略與永續培訓


    1 INTRODUCTION…………………………………………………………….…1
    1.1 PURPOSE OF THE RESEARCH…………………………………………………………..2
    1.2 MAIN THEMES…………………………………………………………………………….2
    1.3 ANALYTICAL FRAMEWORK & CHAPTER ARRANGEMENTS…………….………..3
    1.4 LITERATURE REVIEW……………………………………………………………………4

    2 GENERAL HISTORY AND DEVELOPMENT OF THE PHARMACEUTICAL INDUSTRY AROUND THE WORLD…………….11
    2.1 HISTORY………………………………………………………….......................................11
    2.2 OVERVIEW OF THE INDUSTRY……………………………..………………………….12
    2.3 INDUSTRY ANALYSIS AND INDUSTRY REVENUES....................................................14
    2.4 INDUSTRY PROSPECTS AND OVERALL ATTRACTIVENESS……………………….18
    2.5 PATENTS AND GENERICS………………………………….…………………………….19
    2.6 SALES AND MARKETING AND ADVERTISING TO PHYSICIANS…………………...19

    3 THE HISTORY AND DEVELOPMENT OF THE PHARMACEUTICAL INDUSTRY IN CHINA………..….………………………………………..22
    3.1 OVERVIEW OF CHINESE PHARMACEUTICAL INDUSTRY……………..….................22
    3.2 NUMBER, SIZE, AND GROWTH ………………………………………..…………………24
    3.3 PRODUCTION LEVELS………………………………………………..................................25
    3.4 DOMESTIC PHARMACEUTICAL COMPANIES AND LOW R&D……………………….25
    3.5 COMPARISON OF CHINESE AND WESTERN PHARMA BUSINESS……..................….28
    3.6 FOREIGN COMPANY MANAGEMENT, FOREIGN COMPANIES, PRODUCTION
    AND R&D……………………………………………………………………………………..29
    3.7 REGULATORY REQUIREMENTS AND GMP COMPLIANCE CERTIFICATION………..42
    3.8 GOVERNMENT DRUG PRICING POLICY AND CENTRALIZED TENDERING
    DRUG PROCUREMENT PROGRAM…………………………………………......………...42
    3.9 COMPARISON OF REGULATORY REQUIREMENTS WITH OTHER COUNTRIES…....43
    3.10 PATENTS OVERVIEW AND INTELLECTUAL PROBLEMS IN CHINA ……...………...43

    4 PHARMACEUTICAL TRAINING AND DEVELOPMENT IN CHINA ..…50
    4.1 MEDICAL REPRESENTATIVES HIRING, TRAINING AND DEVELOPMENT……...…...50
    4.2 AREA MANAGER TRAINING AND DEVELOPMENT………………………...….……….52
    4.3 TRAINER TRAINING AND DEVELOPMENT……………………………..…….…….…...53
    4.4 EMERGENCY TRAINING………………..……………….………………………...…….….53
    4.5 EXPECTATION AND SUSTAINABILITY…………………………...…….…….……….….54
    4.6 CONTINUOUS TRAINING/SUSTAINABILITY ACROSS CHINA……………….…….….54

    5 CONCLUSIONS …………………………………………………………..…....56

    REFERENCES…………………………………………………………………..….61

    ACHEMASIA Trend Report No.2: China's pharmaceutical industry "Rapid growth in pharmaceuticals" http://www.achemasia.de/data/achemasia_/trend_report_2_e.htm

    Bayer China http://www.bayer.com.cn/

    BEST PRACTICES, LLC "Pharmaceutical Sales Training: Turning New Hires into Top Performers" 2007 http://www3.best-in-class.com/bestp/domrep.nsf/Content/F1DEFF19A7B5F1718525718F0078C863!OpenDocument

    Bharat Book Bureau. "World Pharmaceutical Market (2007)" 2006 http://www.bharatbook.com/bookdetail.asp?bookid=24220&publisher

    Biocompare. "First-Year Sales Training Critical To Success Of Pharmaceutical Reps" January 2007 http://news.biocompare.com/newsstory.asp?id=166625

    Bitpipe. "Pharmaceutical Industry" 2007 http://www.bitpipe.com/rlist/term/Pharmaceutical-Industry.html

    Business Link. “Joint Ventures and Partnering” http://www.businesslink.gov.uk/bdotg/action/detail?r.l1=1074404796&r.l3=1073864682&r.t=RESOURCES&type=RESOURCES&itemId=1075411648&r.i=1075411671&r.l2=1074404799&r.s=sc

    California State University Stanislaus "Pharmaceutical Industry" http://web.csustan.edu/manage/harris/industry1.html

    ChinaVentureNews "Warburg & CITIC Funds China Pharmaceuticals" November 9, 2005 http://www.chinaventurenews.com/50226711/warburg_citic_funds_china_pharmaceuticals.php

    Cockburn R et al. “The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers” PLoS Medicine Vol. 2 Issue 4, April 2005

    Ebisch R. "Prescription for change" Teradata March 2005 http://www.teradata.com/t/page/131951/index.html

    Eisai. "Major Milestones" http://www.eisai.com/timeline.asp?ID=142

    Forbes.com. "Bayer Expands China Presence" October 26, 2006
    http://www.forbes.com/markets/2006/10/26/bayer-topsun-science-markets-equity-cx_as_1026markets17.html

    FriedlNet. "Analysis : The Chinese Pharmaceutical Industry" March 24, 2003 http://www.friedlnet.com/news/02112306.html

    GIIChinese.com.tw "Pharmaceutical Sales Training Groups - Building Better Sales Forces" December, 2006 http://www.giichinese.com.tw/chinese/cei46279-pharma-sales.html

    Gong Y. “Pharma Moves Ahead Cautiously in China”. Science Vol. 309 29th July 2005 page 735 http://www.sciencemag.org/cgi/content/summary/309/5735/735?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=Pharma+Moves+Ahead+Cautiously+in+China&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT

    Herper M. "World's 10 Best-Selling Drugs" WIRED NEWS. March 28, 2006 http://www.wired.com/news/technology/1,70508-0.html

    Horsten J & Van Cauterenleerstoel IR “Janssen China: Case Study Opportunities for SME’s in China” Horsten International November 2006 http://www.horsten.be/index_files/home.htm

    IMS. "IMS Reports 11.5 Percent Dollar Growth in '03 U.S. Prescription Sales " February 17, 2004 http://www.imshealth.com/ims/portal/front/articleC/0,2777,6599_3665_44771558,00.html

    Liu X. et al. “Drug policy in China. Transformations, current status and future prospects.” Pharmacoeconomics 1997 Jul;12(1):1-9

    Malvern. "Pharmaceutical Industry Overview " 2007 http://www.malvern.co.uk/ProcessEng/industries/pharma/overview.htm

    Market Research Centre and the Canadian Trade Commissioner Service. “The Biotechnology Market in China”. November 2001. http://ats.agr.ca/asia/e3254.htm

    Market Research.com. "China's Pharmaceutical Industry: Growth Prospects" August 1998 http://www.marketresearch.com/browse.asp?categoryid=179&sortby=d&g=1&page=10

    Moynihan et al. “Selling sickness: the pharmaceutical industry and disease mongering” BMJ. 2002 Apr 13;324(7342): 886-91

    Myers K. “Marketing to Professionals: Tomorrow's Changes Today” January 2007 http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=395598

    NBET. "Antitrust Enforcement In Pharmaceutical Industry Mergers" January 2003 http://jobfunctions.bnet.com/whitepaper.aspx?docid=78634

    Novartis China http://www.novartis.com.cn/

    Parry J. “Drug company pulls out of Chinese lawsuit over diabetes drug.” BMJ. 2004 Aug 28;329(7464):476.

    Pfizer China http://www.pfizer.com.cn/

    Piribo. "Business Opportunities in China The Impact of the WTO" March 2006 http://www.piribo.com/publications/country/asia_pacific/china/business_opportunities_china.html

    PWC. "China: Prescription for growth" http://www.pwc.com/extweb/pwcpublications.nsf/docid/2992C71A5CA9BE1285256F5000662664

    Ramsurun J. “Profile Changing China” China Healthcare Consulting September 2002 pg. 265-269 http://www.chccgroup.com/Archive/PPR%20China%20doc.pdf

    REDORBIT "The Impact of China's Fast Growing Pharmaceutical Industry" February 6, 2006 http://www.redorbit.com/news/display/?id=381333

    Reed Elsevier "Reed Exhibitions and Sinopharm agree joint venture" August 29, 2005 http://www.reed-elsevier.com/index.cfm?Articleid=1445

    Robinson JT. “Changing the Face of Detailing by Motivating Physicians to See Pharmaceutical Sales Reps” November 2003 http://www.healthbanks.com/PatientPortal/Public/support_documents/PMT_Robinson.pdf

    SHAANXI ASSOCIATION OF ENTERPRISES WITH FOREIGN INVESTMENT. "The Largest Joint-Venture Pharmaceutical Enterprise in China" September 14, 2006 http://saefi.sxdofcom.gov.cn/2006/9-14/15281884521.asp

    Shijiazhuang Pharmaceutical Group Co.,Ltd http://www.e-cspc.com/english/

    Smith A. "Pfizer to cut 10,000 jobs, shut 5 plants" CNNMoney.com January 22, 2007 http://money.cnn.com/2007/01/22/news/companies/pfizer/index.htm?postversion=2007012216

    Sommerville Q. “China tightens net on fake drugs” BBC News, Shanghai. February 9, 2007 http://news.bbc.co.uk/2/hi/asia-pacific/6345165.stm

    State Intellectual Property Office of P.R.C. "White Paper on the Intellectual Property Rights Protection in China in 1998" March 6, 2002 http://www.sipo.gov.cn/sipo_English/ndbg/bps/200203/t20020306_33981.htm

    Stone R & Xin H. “CHINESE DRUG RESEARCH: Novartis Invests $100 Million in Shanghai” Science November 17, 2006: Vol. 314. no. 5802, pp. 1064 – 1065 http://www.sciencemag.org/cgi/content/full/314/5802/1064b

    Takeda China http://www.takeda.com/worldwide/cn/index.html

    The Economist "Joint ventures in China Wahaha-haha!" April 19, 2007 http://www.economist.com/business/displaystory.cfm?story_id=9040416

    Tomlinson R. “China cracks down on counterfeit medicines.” BMJ. 1999 Mar 6;318(7184):624.

    Trombetta B. "2005 Industry Audit " PharmExec.com September 1, 2005. http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=177964

    Vanhonacker WR. "GSB ChinaWISE 2005: When good guanxi turns bad " UCT Graduate School of Business Newsline 2006 http://www.gsb.uct.ac.za/newsletter/newsletterArticle.ASP?intArticleID=878

    Wang MW et al. “China Evolves from Imitation to Innovation”. Drug Discovery & Development. 2005 http://www.dddmag.com/ShowPR.aspx?PUBCODE=016&ACCT=1600000100&ISSUE=0506&RELTYPE=PR&ORIGRELTYPE=RR&PRODCODE=00000000&PRODLETT=A

    Wang YR. “Price competition in the Chinese pharmaceutical market.” Int J Health Care Finance Econ. 2006 Jun; 6(2):119-29.

    Weinstein M. “Satellite Success: Is IDL Right for You?” Training January/February 2007 page 36

    Wen T. “Growing with China, the Bayer way” China Business Weekly. May 16-22, 2005 page 7

    Wikipedia “Joint Venture” 2007
    http://en.wikipedia.org/wiki/Joint_ventures

    Wikipedia “Pharmaceutical Company” 2006 http://en.wikipedia.org/wiki/Pharmaceutical_company

    Wikipedia “Pharmaceuticals in China” 2007 http://en.wikipedia.org/wiki/Pharmaceuticals_%28China%29

    Xinhua-PRNewswire. "Sinovac Biotech Ltd. Begins Pandemic Flu (H5N1) Vaccine Clinical Trials " December 21, 2005 http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/12-21-2005/0004237948&EDATE

    Yangtze River Pharmacy Group http://www.yangtzeriver.com/english/index.htm

    Young LW. "Protection of Pharmaceuticals in China" September 1999 http://www.wangandwang.com/pharmic.htm

    “薄利多銷” Acme Translation Co.,Ltd http://www.paper-translation.com/words/b9.html

    無法下載圖示 此全文未授權公開
    QR CODE
    :::